 | |
 | |
| Clinical data | |
|---|---|
| Other names | 4-Methylseleno-2,5-dimethoxyphenethylamine; |
| Routes of administration | Oral[1] |
| Drug class | Serotonergic psychedelic;Hallucinogen[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | 45 minutes[1] |
| Duration of action | 6–8 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C11H17NO2Se |
| Molar mass | 274.233 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 240 to 241 °C (464 to 466 °F) |
| |
2C-Se, also known as4-methylseleno-2,5-dimethoxyphenethylamine, is apsychedelic drug of thephenethylamine and2C families.[1] It was originally named byAlexander Shulgin as described in his 1991 bookPiHKAL (Phenethylamines I Have Known and Loved).[1] Shulgin listed its dose as perhaps 100 mgorally and itsduration as 6 to 8 hours.[1] Itsonset was 45 minutes, peak effects occurred after 1.5 hours, and doses of 50 to 70 mg orally produced threshold effects.[1] Shulgin considered 2C-Se to be around three times thepotency ofmescaline, but was too concerned abouttoxicity to test it extensively, though he considered it noteworthy as the only psychedelic drug to contain aselenium atom.[1][2][3][4][5] 2C-Se was first described in the literature by Shulgin inPiHKAL in 1991.[1] It is acontrolled substance inCanada under phenethylamine blanket-ban language.[6]
 | Thishallucinogen-related article is astub. You can help Wikipedia byadding missing information. |
